Glutathione and infection

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 5, 2013, Pages 3329-3349

  Morris, Devin ^a   Khurasany, Melissa ^a   Nguyen, Thien ^a   Kim, John ^a   Guilford, Frederick ^b   Mehta, Rucha ^a   Gray, Dennis ^a   Saviola, Beatrice ^a   Venketaraman, Vishwanath ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b Your Energy Systems   (United States)

Author keywords

Adaptive immunity; AIDS; Glutathione; HIV; Innate immunity; Macrophage; Mycobacterium tuberculosis; NK cell; T cell

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ANTHELMINTIC AGENT; ANTIRETROVIRUS AGENT; ANTITRYPANOSOMAL AGENT; BENZALDEHYDE DERIVATIVE; BENZNIDAZOLE; BUTHIONINE SULFOXIMINE; CHLOROQUINE; GAMMA INTERFERON; GLUTATHIONE; HEXOSAMINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 27; INTERLEUKIN 6; ISONIAZID; NIFURTIMOX; NITRIC OXIDE; PLACEBO; PLANT EXTRACT; PROTEIN KINASE C; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; S NITROSOGLUTATHIONE; TRYPANOTHIONE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ADJUVANT THERAPY; AFRICAN TRYPANOSOMIASIS; ANAPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL GROWTH; BRAIN MALARIA; BRONCHOSPASM; CACHEXIA; CHAGAS DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTRAST INDUCED NEPHROPATHY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DIABETES MELLITUS; ESCHERICHIA COLI; FEVER; FIBROSING ALVEOLITIS; GLUTATHIONE METABOLISM; GROWTH INHIBITION; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION; INFECTION SENSITIVITY; INNATE IMMUNITY; INTRACELLULAR KILLING; KINETOPLASTIDA; LEISHMANIA; LIVER FAILURE; LOADING DRUG DOSE; LUNG TUBERCULOSIS; MACROPHAGE; MIXED INFECTION; MONOCYTE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NATURAL KILLER CELL; NAUSEA; NEMATODE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PARASITE SURVIVAL; PLATYHELMINTH; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TOXIC HEPATITIS; TRYPANOSOMA; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; VOMITING;

ANIMALS; ANTI-INFECTIVE AGENTS; GLUTATHIONE; HUMANS; IMMUNE SYSTEM; INFECTION; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS; PROTOZOA;

EID: 84875717291     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.10.012     Document Type: Review

References (266)

1. A. Meister, and M.E. Anderson Glutathione Annu. Rev. Biochem. 52 1983 711 760
2. A. Meister Selective modification of glutathione metabolism Science 220 1983 472 477
3. M.E. Anderson, and A. Meister Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis Proc. Natl. Acad. Sci. U.S.A. 80 1983 707 711
4. O. Carmel-Hare, and G. Storz Roles of the glutathione and thioredoxin dependent reduction systems in the Escherichia coli and Saccharomyces cervisiae responses to oxidative stress Annu. Rev. Microbiol. 54 2000 439 461
5. C.A. Henard, T.J. Bourret, M. Song, and A. Vazquez-Torres Control of redox balance by the stringent response regulatory protein promotes antioxidant defenses of Salmonella J. Biol. Chem. 285 2010 36785 36793
6. G.V. Smirnova, and O.N. Oktyabrsky Glutathione in bacteria Biochemistry (Mosc.) 70 2005 1199 1211
7. B. Zechmann, A. Tomasic, L. Horvat, and H. Fulgosi Subcellular disruption of glutathione and cysteine in cyanobacteria Protoplasma 246 2010 65 72
8. B.E. Janowiak, and O.W. Griffith Glutathione synthesis in Streptococcus agalactiae J. Biol. Chem. 280 2005 11829 11839
9. S. Gopal, I. Borovok, A. Ofer, M. Yanku, G. Cohen, W. Goebel, J. Kreft, and Y. Aharonowitz A multidomain fusion protein in Listeria monocytogenes catalyzes the two primary activities for glutathione biosynthesis J. Bacteriol. 187 2005 3839 3847
10. B. Verguan, D.D. Vos, and J.J. Van Beemen Characterization of the bifunctional gamma-glutamate-cysteine ligase/glutathione synthetase (GshF) of Pasteurella multocida J. Biol. Chem. 281 2006 4380 4394
11. W. Li, J. Yang, and Q. Ye Production of glutathione using a bifunctional enzyme encoded by gshF from Streptococcus thermophilus expressed in Escherichia coli J. Biotechnol. 154 2011 261 268
12. N. Allocati, L. Frederici, M. Masulli, and C.D. Ilio Glutathione trasferases in bacteria FEBS J. 276 2008 58 75
13. N. Allocati, L. Frederici, M. Masulli, and C.D. Ilio Distribution of glutathione trasferases in gram-positive bacteria and archaea Biochimie 2011 1 9
14. J.D. Hoerter, A.A. Arnold, D.A. Kuczynska, A. Shibuya, C.S. Ward, M.G. Sauer, A. Gizachew, T.M. Hotchkiss, T.J. Fleming, and S. Johnson Effects of sublethal UVA irradiation on activity levels of oxidative defense enzymes and protein oxidation in Escherichia coli J. Photochem. Photobiol. B 81 2005 171 180
15. K. Alkhuir, K.L. Meibom, I. Dubail, M. Dupuis, and A. Charbit Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis PLoS Pathog. 5 2009 e1000284
16. C. Sherrill, and R.C. Fahey Import and metabolism of glutathione by Streptococcus mutans J. Bacteriol. 180 1998 1454 1459
17. B. Vergauwen, F. Pauwels, M. Vaneechoutte, and J.J. Van Beeumen Exogenous glutathione completes the defense against oxidative stress in Haemophilus influenzae J. Bacteriol. 185 2003 1572 1581
18. B. Vergauwen, F. Pauwels, and J.J. Van Beeumen Glutathione and catalase provide overlapping defenses for protection against respiration-generated hydrogen peroxide in Haemophilus influenzae J. Bacteriol. 185 2003 5555 5562
19. B. Verguanwen, J. Elegheert, A. Dansercoer, B. Deveese, and S.N. Savvides Glutathione import in Haemophilus influenzae Rd is primed by the periphlasmic heme-binding protein HbpA Proc. Natl. Acad. Sci. U.S.A. 107 2010 13270 13275
20. Y.K. Dayaram, M.T. Talaue, N.D. Connell, and V. Venketaraman Characterization of glutathione metabolic mutants of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathione J. Bacteriol. 188 2006 1364 1372
21. F. Fan, M.W. Vetting, P.A. Frantom, and J.S. Blanchard Structures and mechanisms of micothiol biosynthetic enzymes Curr. Opin. Chem. Biol. 13 2009 451 459
22. V. Venketaraman, Y.K. Dayaram, A.G. Amin, R. Ngo, R.M. Green, M.T. Talaue, J. Mann, and N.D. Connell Role of glutathione in macrophage control of mycobacteria Infect. Immun. 71 2003 1864 1871
23. L. Chu, Z. Dong, X. Xu, D.L. Cochran, and J.L. Ebersole Role of glutathione metabolism of Treponema denticola in bacterial growth and virulence expression Infect. Immun. 70 2002 1113 1120
24. K. Helbig, C. Bleuel, G.J. Krauss, and D.H. Nies Glutathione and transition-metal homeostasis in Escherichia coli J. Bacteriol. 190 2008 5431 5438
25. J. Zhang, G.D. Du, Y. Zhang, X.Y. Liao, M. Wang, Y. Li, and J. Chen Glutathione protects Lactobacillus sanfranciscensis against freeze-thawing, freeze-drying, and cold treatment Appl. Environ. Microbiol. 76 2010 2989 2996
26. Y. Zhang, D. Meng, Z. Wang, H. Guo, and Y. Wang Oxidative stress response in two representative bacteria exposed to atrazine FEMS Microbiol. Lett. 334 2 Sep 2012 95 101
27. J.C. Cameron, and H.B. Pakrasi Glutathione facilitates antibiotic resistance and photosystem I stability during exposure to gentamicin in cyanobacteria Appl. Environ. Microbiol. 77 2011 3547 3550
28. A. Carius, M. Henkel, and G. Hartmut A gluthathione redox effect on photosynthesic membrane expression in Rhodospirillum rybum J. Bacteriol. 193 2011 1893 1900
29. A. Achuthan, R.K. Duary, A. Madathil, H. Panwar, H. Kumar, V.K. Batish, and S. Grover Antioxidant potential of Lactobacilli isolated from the gut of Indian people Mol. Biol. Rep. 39 2012 7887 7897
30. WHO Global Tuberculosis Control-Survelliance, Planning, Financing 2008 World Health Organization Geneva http://www.who.int/tb/publications/global- report/2008/introduction/en/index.html
31. E.L. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, M.C. Raviglione, and C. Dye The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch. Intern. Med. 163 2003 1009 1021
32. V. Venketaraman, A. Millman, M. Salman, S. Swaminathan, M. Goetz, A. Lardizabal, D. Hom, and N.D. Connell Glutathione levels and immune responses in tuberculosis patients Microb. Pathog. 44 2008 255 261 10.1016/j.micpath.2007.09. 002
33. T.J. Kindt, R.A. Goldsby, and B.A. Osborne Kuby Immunology Sixth ed. 2007 W.H. Freeman and Company New York Print
34. H.G. Boman Gene-encoded peptide antibiotics and the concept of innate immunity: an updated review Scand. J. Immunol. 48 1998 15 25
35. C. Nathan, and M.U. Shiloh Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens Proc. Natl. Acad. Sci. U.S.A. 97 2000 8841 8848
36. N.W. Schluger, and W.N. Rom The host immune response to tuberculosis Am. J. Respir. Crit. Care Med. 157 1998 679 691
37. T.K. Van Heyningen, H.L. Collins, and D.G. Russell IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses J. Immunol. 158 1996 330 337
38. M. Denis Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol Clin. Exp. Immunol. 84 1991 200 206
39. J. Chan, R. Zin, S. Magliozzo, and B.R. Bloom Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages J. Exp. Med. 175 1992 1111 1122
40. I. Flesch, and S.H. Kaufmann Mycobacterial growth inhibition by interferon-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis J. Immunol. 138 1987 4408 4413
41. K.A. Rockett, R. Brookes, I. Udalova, V. Vidal, A.V. Hill, and D. Kwiatkowski 1,25-Dihydroxyvitamin-D3 induces nitric oxide and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line Infect. Immun. 66 1998 5314 5321
42. U.E. Schaible, S.S. Koszycki, P.H. Schlesinger, and D.G. Russell Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages J. Immunol. 160 1998 1290 1296
43. T. Seres, R.G. Knickelbein, J.B. Warshaw, and R.B. Johnston Jr. The phagocytosis-associated respiratory burst in human monocytes is associated with increased uptake of glutathione J. Immunol. 165 2000 3333 3340
44. J. MacMicking, Q.W. Xie, and C. Nathan Nitric oxide and macrophage function Annu. Rev. Immunol. 15 1997 323 350
45. Y.K. Dayaram, M.T. Talaue, N.D. Connell, and V. Venketaraman Characterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathione J. Bacteriol. 188 2006 1364 1372
46. A.M. Cooper, J.E. Pearl, J.V. Brooks, S. Ehlers, and I.M. Orme Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung Infect. Immun. 68 2000 6879 6882
47. E.D. Chan, J. Chan, and N.W. Schluger What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge Am. J. Respir. Cell Mol. Biol. 25 2001 606 612
48. M. Balazy, P.M. Kaminski, K. Mao, J. Tan, and M.S. Wolin S-Nitroglutathione, a product of the reaction between peroxynitrite and glutathione that generates nitric oxide J. Biol. Chem. 273 1998 32009 32015
49. M.A. De Groote, D. Granger, Y. Xu, G. Campbell, R. Prince, and F.C. Fang Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model Proc. Natl. Acad. Sci. U.S.A. 92 1995 6399 6403
50. D. Nikitovic, and A. Holmgren S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide J. Biol. Chem. 271 1996 19180 19185
51. R.M. Green, A. Seth, and N.D. Connell A peptide permease mutant of Mycobacterium bovis BCG resistant to the toxic peptides glutathione and S-nitrosoglutathione Infect. Immun. 68 2000 429 436
52. V. Venketaraman, Y.K. Dayaram, M.T. Talaue, and N.D. Connell Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis Infect. Immun. 73 2005 1886 1889
53. G.L. Newton, and R.C. Fahey Mycothiol biochemistry Arch. Microbiol. 178 2002 388 394
54. S.J. Anderberg, G.L. Newton, and R.C. Fahey Micothiol biosynthesis and metabolism; Cellular levels of potential intermediates in the biosynthesis and degredation of mycothiol in Mycobacterium smegmatis J. Biol. Chem. 273 1998 30391 30397
55. J.E. Spallholz Glutathione: is it an evolutionary vestige of the penicillins? Med. Hypotheses 23 1987 253 257
56. K. Incze, J. Farkas, V. Mihalyi, and E. Zukal Antibacterial effect of cysteine-nitrosothiol and possible percursors thereof Appl. Microbiol. 27 1974 202 205
57. C. Jagannath, J.K. Actor, and R.L. Hunter Jr. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis Nitric Oxide 2 1998 74 86
58. D. Morris, C. Guerra, C. Donohue, H. Oh, M. Khurasany, and V. Venketaraman Unveiling the mechanisms for decreased glutathione in individuals with HIV infection Clin. Dev. Immunol. 2012 1 10 10.1155/2012/734125
59. K.J. Brill, Q. Li, R. Larkin, D.H. Canaday, D.R. Kaplan, W.H. Boom, and R.F. Silver Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms Infect. Immun. 69 2001 1755 1765
60. M. Denis Interlukin-12 (IL-12) augments cytolitic activity of natural killer cells toward Mycobacterium tuberculosis-infected human monocytes Cell. Immunol. 156 1994 529 536
61. K.V. Harshan, and P.R. Gangadharam In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice Infect. Immun. 59 1991 2818 2821
62. T. Yoneda, and J.J. Ellner CD4 + T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes Am. J. Respir. Crit. Care Med. 158 1998 395 403
63. C. Guerra, K. Johal, D. Morris, S. Moreno, O. Alvarado, D. Gray, M. Tanzil, D. Pearce, and V. Venketaraman Control of Mycobacterium tuberculosis growth by activated natural killer cells Clin. Exp. Immunol. 168 2012 142 152
64. A.C. Millman, M. Salman, Y.K. Dayaram, N.D. Connell, and V. Venketaraman Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis J. Interferon Cytokine Res. 28 2008 153 165
65. M. Kasai, T. Yoneda, S. Habu, Y. Maruyama, K. Okumura, and T. Tokunaga In vivo effect of anti-asialo GM1 antibody on natural killer activity Nature 291 1981 334 335
66. W.G. Morice The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders Am. J. Clin. Pathol. 127 2007 881 886
67. L. Moretta, R. Biassoni, C. Bottino, M.C. Mingari, and A. Moretta Human NK-cell receptors Immunol. Today 21 2000 420 422
68. S. Sivori, M. Vitale, L. Morelli, L. Sanseverino, R. Augugliaro, C. Bottino, L. Moretta, and A. Moretta p46, a novel natural killer cell-specific surface molecule that mediates cell activation J. Exp. Med. 186 1997 1129 1136
69. M. Vitale, C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Auqugliaro, L. Moretta, and A. Moretta NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis J. Exp. Med. 12 1998 2065 2072
70. D. Pende, S. Parolini, A. Pressino, S. Sivori, and R. Augugliaro Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells J. Exp. Med. 190 1999 1505 1516
71. R. Vankalayapati, B. Wizel, S.E. Weis, H. Safi, D.L. Lakey, O. Mandelboim, B. Samten, A. Porgador, and P.F. Barnes The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium J. Immunol. 168 2002 3451 3457
72. Y. Oshimi, S. Oda, Y. Honda, S. Nagata, and S. Miyazaki Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells J. Immunol. 157 1996 2909 2915
73. E. Carbone, G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction J. Exp. Med. 185 1997 2053 2060
74. G. Pietro Role of glutathione in immunity and inflammation in the lung Int. J. Gen. Med. 4 2011 105 113
75. Y.H. Chien, and M.M. Davis How alpha beta T-cell receptors 'see' peptide/MHC complexes Immunol. Today 14 1993 597 602
76. S. Short, B.J. Merkel, R. Caffrey, and K.L. McCoy Defective antigen processing correlates with a low level of intracellular glutathione Eur. J. Immunol. 26 1996 3015 3020
77. B. Arunachalam, U.T. Phan, and H.J. Geuze Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT) Proc. Natl. Acad. Sci. U.S.A. 97 2000 745 750
78. J.A. D'Angelo, E. Dehlink, B. Platzer, P. Dwyer, M.L. Circu, J. Garay, T.Y. Aw, E. Fiebiger, and B.L. Dickinson The cystine/glutamate antiporter regulates dendritic cell differentiation and antigen presentation J. Immunol. 185 2010 3217 3226
79. C. Guerra, D. Morris, A. Sipin, S. Kung, M. Franklin, D. Gray, M. Tanzil, F. Guilford, F.T. Khasawneh, and V. Venketaraman Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals PLoS One 6 2011 e28378
80. Z. Yan, S.K. Garg, and R. Banerjee Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells J. Biol. Chem. 285 2010 41525 41532
81. E. Ristoff, and A. Larsson Inborn errors in the metabolism of glutathione Orphanet J. Rare Dis. 2 2007 16
82. D.G. Russell, P.J. Cardona, M.J. Kim, S. Allain, and F. Altare Foamy macrophages and the progression of the human tuberculosis granuloma Nat. Immunol. 10 2009 943 948
83. L.S. Meena, and M. Rajni Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv FEBS J. 277 2010 2416 2427
84. Z. Yan, and R. Banerjee Redox remodeling as an immunoregulatory strategy Biochemistry 49 2010 1059 1066
85. S.K. Garg, Z. Yan, V. Vitvitsky, and R. Banerjee Differential dependence on cysteine from transsulfuration versus transport during T cell activiation Antioxid. Redox Signal. 15 2011 39 47
86. A. Martner, J. Aurelius, A. Rydstrom, K. Hellstrand, and F.B. Thoren Redox remodeling by dendritic cells protects antigen-specific T cells against oxidative stress J. Immunol. 187 2011 6243 6248
87. D.A. Hildeman Regulation of T-cell apoptosis by reactive oxygen species Free Radic. Biol. Med. 36 2004 1496 1504
88. D.M. Lowe, P.S. Redford, R.J. Wilkinson, A. O'Garra, and A.R. Martineau Neutrophils in tuberculosis: friend or foe? Trends Immunol. 33 2012 14 25
89. P. Kidd Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease Altern. Med. Rev. 8 2003 223 246
90. R.V. Luckheeram, R. Zhou, A.D. Verma, and B. Xia CD4+T cells: differentiation and functions Clin. Dev. Immunol. 2012 2012 925135
91. C.A. Janeway Jr., P. Travers, M. Walport, and M.J. Shlomchik Immunobiology: The Immune System in Health and Disease Fifth ed. 2001 Garland Science New York
92. A. Fraternale, M.F. Paoletti, S. Dominici, C. Buondelmonte, A. Caputo, A. Castaldello, A. Tripiciano, A. Cafaro, A.T. Palamara, R. Sqarbanti, E. Garaci, B. Ensoli, and M. Maqnani Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules Vaccine 29 2011 6823 6829
93. V. Venketaraman, T. Rodgers, R. Linares, N. Reilly, S. Swaminathan, D. Hom, A.C. Millman, R. Wallis, and N.D. Connell Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects AIDS Res. Ther. 3 2006 1 12
94. V. Verhasselt, W. Vanden Berghe, N. Vanderheyde, F. Willems, G. Haegeman, and M. Goldman N-acetyl-l-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition J. Immunol. 162 1999 2569 2574
95. G. Bernal-Fernandez, P. Espinosa-Cueto, R. Leyva-Meza, N. Mancilla, and R. Mancilla Decreased expression of T-cell costimulatory molecule CD28 on CD4 and CD8 T cells of Mexican patients with pulmonary tuberculosis Tuberc. Res. Treat. 2010 2010 51754
96. K. Bhatt, A. Uzelac, S. Mathur, A. McBride, J. Potian, and P. Salgame B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection J. Immunol. 182 2009 3793 3800
97. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
98. K. Rutault, C. Alderman, B.M. Chain, and D.R. Katz Reactive oxygen species activate human peripheral blood dendritic cells Free Radic. Biol. Med. 26 1999 232 238
99. G. Angelini, S. Gardella, M. Ardy, M.R. Ciriolo, G. Filomeni, G. DiTrapani, F. Clarke, R. Sitia, and A. Rubartelli Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation Proc. Natl. Acad. Sci. U.S.A. 99 2002 1491 1496
100. Z. Yan, S.K. Garg, J. Kipnis, and R. Banerjee Extracellular redox modulation by regulatory T cells Nat. Chem. Biol. 5 2009 721 723
101. C.A. Dinarello Proinflammatory cytokines Chest 118 2000 503 508
102. L. Young, P.C. Blumbergs, N.R. Jones, J. Manavis, G.T. Sarvestani, and M.N. Ghabriel Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury Spine (Phila Pa 1976) 29 2004 966 971
103. H.J. Kim, B. Barajas, R.C. Chan, and A.E. Nel Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence J. Allergy Clin. Immunol. 119 2007 1225 1233
104. Y. Kamide, M. Utsugi, K. Dobashi, A. Ono, T. Ishizuka, T. Hisada, Y. Koga, K. Uno, J. Hamuro, and M. Mori Intracellular glutathione redox status in human dendritic cells regulates IL-27 production and T-cell polarization Allergy 66 2011 1183 1192
105. WHO Global Summary of the AIDS epidemic 2010 http://www.who.int/ mediacentre/factsheets/fs360/en/index.html 2011
106. AIDS.gov Opportunistic Infections and their relationship to HIV http://aids.gov/hiv-aids-basics/staying-healthy-with-hiv-aids/ potential-related-health-problems/opportunistic-infections/ 2012
107. D.C. Douek, J.M. Brenchley, M.R. Betts, D.R. Ambrozak, B.J. Hill, Y. Okamoto, J.P. Cassazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. Dybul, A. Oxenius, D.A. Price, M. Connor, and R.A. Koup HIV preferentially infects HIV specific CD4 + T cells Nature 417 2002 95 98
108. Leeansyah, J. Zhou, G. Paukovics, S.R. Lewin, S.M. Crowe, and J. Jaworowski Decreased NK cell FcRγ in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study PLoS One 5 2010 e9643
109. World Health Organization Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access (2010) http://www.who.int/ entity/hiv/pub/progress-report2011/summary-en.pdf
110. C.Y. Chiang, R. Centis, and G.B. Migliori Drug-resistant tuberculosis: past, present, future Respirology 15 2010 413 432
111. N.K. Dutta, S. Mehra, and D. Kaushal A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine PLoS One 5 2010 e10069
112. G.A. Rook Progress in the immunology of the mycobacterioses Clin. Exp. Immunol. 69 1987 1 9
113. J.L. Rothstein, T.F. Lint, and H. Schreiber Tumor necrosis factor/cachectin; Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5) J. Exp. Med. 168 1988 2007 2021
114. R.M. Strieter, S.L. Kunkel, and R.C. Bone Role of tumor necrosis factor-alpha in disease states and inflammation Crit. Care Med. 21 1993 S447 S463
115. R. Buhl, H.A. Jaffe, K.J. Holroyd, F.B. Wells, A. Mastrangeli, C. Saltini, A.M. Cantin, and R.G. Crystal Systemic glutathione deficiency in symptom-free HIV-seropositive individuals Lancet 2 1989 1294 1298
116. B. De Quay, R. Malinverni, and B.H. Lauterburg Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine AIDS 6 8 1992 815 819
117. H.P. Eck, H. Gmunder, M. Hartmann, D. Petzoldt, V. Daniel, and W. Droge Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients Biol. Chem. Hoppe Seyler 370 1989 101 108
118. B. Helbling, J. Overbeck, and B.H. Lauterburg Decreased release of glutathione into the systemic circulation of patients with HIV infection Eur. J. Clin. Investig. 26 1996 38 44
119. C.L. Daley, P.M. Small, G.F. Schecter, G.K. Schoolnik, R.A. McAdam, W.R. Jacob Jr., and P.C. Hopewell An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus; an analysis using restriction-fragment-length polymorphisms N. Engl. J. Med. 326 1992 231 235
120. J.S. Stamler Redox signaling: nitrosylation and related target interactions of nitric oxide Cell 78 1994 931 936
121. R. Buhl, C. Vogelmeier, M. Critenden, R.C. Hubbard, R.F. Hoyt Jr., E.M. Wilson, A.M. Cantin, and R.G. Crystal Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol Proc. Natl. Acad. Sci. U.S.A. 87 1990 4063 4067
122. J.H. Roum, Z. Borok, N.G. McElvaney, G.J. Grimes, A.D. Bokser, R. Buhl, and R.G. Crystal Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis J. Appl. Physiol. 87 1999 438 443
123. Centers for Disease Control (CDC) http://www.cdc.gov/diabetes/statistics/ prev/national/figpersons.htm 2011
124. E.J. Rayfield, M.J. Ault, G.T. Keusch, M.J. Brothers, C. Nechemias, and H. Smith Infection and diabetes: the case for glucose control Am. J. Med. 72 1982 439 450
125. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
126. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605
127. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ. Res. 107 2010 1058 1070
128. G. Pugliese, F. Pricci, F. Pugliese, P. Mene, L. Lenti, D. Andreani, G. Galli, A. Casini, S. Bianchi, and C.M. Rotella Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells Diabetes 43 1994 478 490
129. P.A. Craven, R.K. Studer, J. Felder, S. Phillips, and F.R. DeRubertis Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells Diabetes 46 1997 671 681
130. R. Kikkawa, M. Haneda, T. Uzu, D. Koya, T. Sugimoto, and Y. Shigeta Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions Diabetologia 37 1994 838 841
131. P.P. Sayeski, and J.E. Kudlow Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription J. Biol. Chem. 271 1996 15237 15243
132. V. Kolm-Litty, U. Sauer, A. Nerlich, R. Lehmann, and E.D. Schleicher High glucose-induced transforming growth factor beta1 production is mediated by hexosamine pathway in porcine glomerular mesangial cells J. Clin. Invest. 101 1998 160 169
133. Y.Q. Chen, M. Su, R.R. Walia, Q. Hao, J.W. Covington, and D.E. Vaughan Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells J. Biol. Chem. 273 1998 8225 8231
134. X.L. Du, D. Edelstein, L. Rossetti, I.G. Fantus, H. Goldberg, F. Ziyadeh, J. Wu, and M. Brownlee Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation Proc. Natl. Acad. Sci. U.S.A. 97 2000 12222 12226
135. P.L. Graham III, S.X. Lin, and E.L. Larson A U.S. population-based survey of Staphylococcus aureus colonization Ann. Intern. Med. 144 2006 318 325
136. J.E. Stalenhoef, B. Alisjahbana, E.J. Nelwan, J. van der Ven-Jongekrijg, T.H.M. Ottenhoff, T.H. Ottenhoff, J.W. Van Der Meer, R.H. Nelwan, M.G. Netea, and R. Van Crevel The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus Eur. J. Clin. Microbiol. Infect. Dis. 27 2008 97 103
137. K. Tsukaguchi, H. Okamura, M. Ikuno, A. Kobayashi, A. Fukuoka, H. Takenaka, C. Yamamoto, T. Tokuyama, Y. Okamoto, A. Fu, M. Yoshikawa, T. Yoneda, and N. Narita The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4p alpha beta T cells and monocytes in patients with pulmonary tuberculosis Kekkaku 72 1997 617 622
138. M. Delamaire, D. Maugendre, M. Moreno, M.C. Le Goff, H. Allannic, and B. Genetet Impaired leucocyte functions in diabetic patients Diabet. Med. 14 1997 29 34
139. C.R. Stevenson, J.A. Critchley, N.G. Forouhi, G. Roglic, B.G. Williams, C. Dye, and N.C. Unwin Diabetes and the risk of tuberculosis: a neglected threat to public health Chronic Illn. 3 2007 228 245
140. K.E. Dooley, and R.E. Chaisson Tuberculosis and diabetes mellitus: convergence of two epidemics Lancet Infect. Dis. 9 2009 737 746
141. C.Y. Jeon, and M.B. Murray Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies PLoS Med. 5 2008 e152
142. R. Ruslami, R.E. Aarnoutse, B. Alisjahbana, A.J. van der Ven, and R. Van Crevel Implications of the global increase of diabetes for tuberculosis control and patient care Trop. Med. Int. Health 15 2010 1289 1299
143. M.A. Baker, A.D. Harries, C.Y. Jeon, J.E. Hart, A. Kapur, K. Lönnroth, S.E. Ottman, S.D. Goonesekera, and M.B. Murray The impact of diabetes on tuberculosis treatment outcomes: a systematic review BMC Med. 9 2011 81
144. M.P. Moutschen, A.J. Scheen, and P.J. Lefebvre Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections Diabetes Metab. 18 1992 187 201
145. F.Y. Chang, and M.F. Shaio Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus Diabetes Res. Clin. Pract. 28 1995 137 146
146. C.C. Leung, T.H. Lam, W.M. Chan, W.W. Yew, K.S. Ho, G.M. Leung, W.S. Law, C.M. Tam, C.K. Chan, and K.C. Chang Diabetic control and risk of tuberculosis: a cohort study Am. J. Epidemiol. 167 2008 1486 1494
147. A. Pablos-Mendez, J. Blustein, and C.A. Knirsch The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics Am. J. Public Health 87 1997 574 579
148. K.S. Tan, K.O. Lee, K.C. Low, A.M. Gamage, Y. Liu, G.Y. Tan, H.Q. Koh, S. Alonso, and Y.H. Gan Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria J. Clin. Invest. 122 2012 2289 2300
149. M.A. Beck Selenium and vitamin E status: impact on viral pathogenicity J. Nutr. 137 2007 1338 1340
150. A. Meister Glutathione, ascorbate, and cellular protection Cancer Res. 54 1994 1969s 1975s
151. P. Boya, A. de la Pena, O. Beloqui, E. Larrea, M. Conchillo, Y. Castelruiz, M.P. Civeira, and J. Prieto Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C J. Hepatol. 31 1999 808 814
152. A.T. Palamara, C.F. Perno, M.R. Ciriolo, L. Dini, E. Balestra, C. D'Agostini, P. Di Francesco, C. Favalli, G. Rotilio, and E. Garaci Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication Antiviral Res. 27 1995 237 253
153. M.R. Ciriolo, A.T. Palamara, S. Incerpi, E. Lafavia, M.C. Bue, P. De Vito, E. Garaci, and G. Rotilio Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection J. Biol. Chem. 272 1997 2700 2708
154. A. Papi, M. Contoli, P. Gasparini, L. Bristot, M.R. Edwards, M. Chicca, M. Leis, A. Ciaccia, G. Caramori, S.L. Johnston, and S. Pinamonti Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells J. Biol. Chem. 283 2008 28595 28606
155. J. Cai, Y. Chen, S. Seth, S. Furukawa, R.W. Compans, and D.P. Jones Inhibition of influenza infection by glutathione Free Radic. Biol. Med. 34 2003 928 936
156. T. Hennet, E. Peterhans, and R. Stocker Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus J. Gen. Virol. 73 1992 39 46
157. E. Peterhans, M. Grob, T. Burge, and R. Zanoni Virus-induced formation of reactive oxygen intermediates in phagocytic cells Free Radic. Res. Commun. 3 1987 39 46
158. E. Peterhans Reactive oxygen species and nitric oxide in viral diseases Biol. Trace Elem. Res. 56 1997 107 116
159. J.A. Imlay, and S. Linn DNA damage and oxygen radical toxicity Science 240 1988 1302 1309
160. S.J. Weiss Tissue destruction by neutrophils N. Engl. J. Med. 320 1989 365 376
161. H.B. Suliman, L.K. Ryan, L. Bishop, and R.J. Folz Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase Am. J. Physiol. Lung Cell. Mol. Physiol. 280 2001 L69 L78
162. D.C. Wiley, and J.J. Skehel The structure and function of the hemagglutinin membrane glycoprotein of influenza virus Annu. Rev. Biochem. 56 1987 365 394
163. D.P. Sarkar, S.J. Morris, O. Eidelman, J. Zimmerberg, and R. Blumenthal Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: cytoplasmic continuity and lipid mixing J. Cell Biol. 109 1989 113 122
164. L. Perez, and L. Carrasco Involvement of the vacuolar H(+)-ATPase in animal virus entry J. Gen. Virol. 75 1994 2595 2606
165. M. Ozawa, A. Asano, and Y. Okada Importance of interpeptide disulfide bond in a viral glycoprotein with hemaglutination and neuraminidase activities FEBS Lett. 70 1976 145 149
166. U. Tatu, C. Hammond, and A. Helenius Folding and oligomerization of influenza hemagglutinin in the ER and the intermediate compartment EMBO J. 14 1995 1340 1348
167. E. Garaci, A.T. Palamara, P. Di Francesco, C. Favalli, M.R. Ciriolo, and G. Rotilio Glutathione inhibits replication and expression of viral proteins in cultured cells infected with Sendai virus Biochem. Biophys. Res. Commun. 188 1992 1090 1096
168. T. Kalebic, A. Kinter, G. Poli, M.E. Anderson, A. Meister, and A.S. Fauci Supression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine Proc. Natl. Acad. Sci. U.S.A. 88 1991 986 990
169. R.C. Vossen, M.C. Persoons, M.E. Slobbe-van Drunen, C.A. Bruggeman, and M.C. Van Dam-Mieras Intracellular thiol redox status affects rat cytomegalovirus infection of vascular cells Virus Res. 48 1997 173 183
170. A. Papi, N.G. Papadopoulos, L.A. Stanciu, C.M. Bellettato, S. Pinamonti, K. Degitz, S.T. Holgate, and S.L. Johnston Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells FASEB J. 16 2002 1934 1936
171. G. Nabel, and D. Baltimore An inducible transcription factor activates expression of human immunodeficiency virus in T cells Nature 326 1987 711 713
172. I. Braakman, J. Helenius, and A. Helenius Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum EMBO J. 11 1992 1717 1722
173. U. Tatu, I. Braakman, and A. Helenius Membrane glycoprotein folding, oligomerization and intracellular transport: effects of dithiothreitol in living cells EMBO J. 12 1993 2151 2157
174. A. De Silva, I. Braakman, and A. Helenius Posttranslational folding of vesicular stomatitis virus G protein in the ER: involvement of noncovalent and covalent complexes J. Cell Biol. 120 1993 647 655
175. I. Braakman, J. Helenius, and A. Helenius Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum Nature 356 1992 260 262
176. R.L. Krauth-Siegel, and A.E. Leroux Low-molecular-mass antioxidants in parasites, antioxid Redox Signal. 2012 10.1089/ars.2011.4392 (epub ahead of print)
177. S. Müller, E. Liebau, R.D. Walter, and R.L. Krauth-Siegel Thiol-based redox metabolism of protozoan parasites Trends Parasitol. 19 2003 320 328
178. A.H. Fairlamb, P. Blackburn, P. Ulrich, B.T. Chait, and A. Cerami Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids Science 227 1985 1485 1487
179. A.H. Fairlamb, and A. Cerami Metabolism and functions of trypanothione in the kinetoplastida Annu. Rev. Microbiol. 46 1992 695 729
180. R.L. Krauth-Siegel, and M.A. Comini Redox control in trypanosomatids, paracitic protozoa with trypanothione-based thiol metabolism Biochim. Biophys. Acta 1780 2008 1236 1248
181. B.A. Arrick, O.W. Griffith, and A. Cerami Inhibition of glutathione synthesis as a chemotheraputic strategy for trypanosomiasis J. Exp. Med. 153 1981 720 725
182. M. Faúndez, R. López-Muñoz, G. Torres, A. Morello, J. Ferreira, U. Kemmerling, M. Orellana, and J.D. Maya Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of Nifurtimox, Antimicrob Agents Chemother. 52 2008 1837 1839
183. M. Faúndez, R. López-Muñoz, L. Pino, P. Letelier, C. Ortiz, R. López, C. Seguel, J. Ferreira, M. Pavani, A. Morello, and J.D. Maya Buthionine sulfoximine increases the toxicity of Nifurtimox and Benznidazole to Trypanosoma cruzi Antimicrob. Agents Chemother. 49 2005 126 130
184. M.R. Ariyanayagam, and A.H. Fairlamb Ovothiola and trypanothione as antioxidants in trypanosomatids Mol. Biochem. Parasitol. 115 2011 189 198
185. K.K. Cruz, S.G. Fonseca, M.C. Monteiro, O.S. Silva, V.M. Andrade, F.Q. Cunha, and P.R. Romão The influence of glutathione modulators on the course of Leishmania major infection in susceptible and resistant mice Parasite Immunol. 30 2008 171 174
186. R. Docampo, S.N.J. Moreno, A.O.M. Stoppani, W. Leon, F.S. Cruz, F. Villalta, and R.F. Muniz Mechanism of Nifurtimox toxicity in different forms of Trypanosoma cruzi Biochem. Pharmacol. 30 1981 1947 1951
187. J.D. Maya, A. Morello, Y. Repetto, R. Rodriguez, P. Puebla, E. Caballero, M. Medarde, L.J. Núñez-Vergara, J.A. Squella, M.E. Ortiz, J. Fuentealba, and A. San Feliciano Trypanosoma cruzi: inhibition of parasite growth and respiration by oxazolo(thiazolo)pyridine derivatives and its relationship to redox potential and lipophilicity Exp. Parasitol. 99 2011 1 6
188. K. Becker, S. Rahlfs, C. Nickel, and R.H. Schirmer Glutathione - functions and metabolism in the malarial parasite Plasmodium falciparum Biol. Chem. 384 2003 551 566
189. H. Atamna, and H. Ginsburg Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum Mol. Biochem. Parasitol. 61 1993 231 241
190. A.O. Wozencraft, H.M. Dockrell, J. Taverne, G.A.T. Targett, and J.H. Playfair Killing of human malaria parasites by macrophage secretory products Infect. Immun. 43 1984 664 669
191. K. Luersen, R.D. Walter, and S. Muller Plasmodium falciparum-infected red blood cells depend on a functional glutathione de novo synthesis attributable to an enhanced loss of glutathione Biochem. J. 346 2000 545 552
192. S. Meierjohann, R.D. Walter, and S. Muller Glutathione synthetase from Plasmodium falciparum Biochem. J. 363 2002 833 838
193. P.M. Farber, K. Becker, S. Muller, R.H. Schirmer, and R.M. Franklin Molecular cloning and characterization of a putative glutathione reductase gene, the PfGR2 gene, from Plasmodium falciparum Eur. J. Biochem. 239 1996 655 661
194. S. Meierjohann, R.D. Walter, and S. Muller Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum Biochem. J. 368 2002 761 768
195. E.M. Patzeqitz, E.H. Wong, and S. Muller Dissecting the role of glutatihone biosynthesis in Plasmodium falciparum Mol. Microbiol. 83 2012 304 318
196. H. Atamna, and H. Ginsburg The malaria parasite supplies glutathione to its host cell: investigation of glutathione transport and metabolisim in human erythrocytes infected with Plasmodium falciparum Eur. J. Biochem. 250 1997 670 679
197. S. Muller Redox and antioxidant systems of the malaria parasite Plasmodium falciparum Mol. Microbiol. 53 2004 1291 1305
198. G.M. Zanini, Y.C. Martins, P. Cabrales, J.A. Frangos, and L.J.M. Carvalho S-nitrosoglutathione prevents experimental cerebral malaria J. Neuroimmune Pharmacol. 2012 10.1007/s11481-012-9343-6
199. A.F.G. Slater, W.J. Swiggard, B.R. Orton, W.D. Flitter, D.E. Goldberg, A. Cerami, and G.B. Henderson An iron-carboxylate bond links the heme units of malaria pigment Proc. Natl. Acad. Sci. U.S.A. 88 1991 325 329
200. A. Dorn, R. Stoffel, H. Matile, A. Bubendorf, and R.G. Ridley Malarial haemozoin/ beta-haematin supports haem polymerization in the absence of protein Nature 374 1995 269 271
201. D.J. Sullivan Jr., I.Y. Gluzman, D.G. Russel, and D.E. Goldberg On the molecular mechanism of Chloroquine's antimalarial action Proc. Natl. Acad. Sci. U.S.A. 93 1996 11865 11870
202. A.C. Chou, and C.D. Fitch Control of heme polymerase by Chloroquine and other quinoline derivatives Biochem. Biophys. Res. Commun. 195 1993 422 427
203. Y. Sugioka, and M. Suzuki The chemical basis for the ferriprotoporphyrin IX-chloroquine complex induced lipid peroxidation Biochim. Biophys. Acta 1074 1991 19 24
204. A.U. Orjih Heme polymerase activity and the stage specificity of antimalarial action of Chloroquine J. Pharmacol. Exp. Ther. 282 1997 108 112
205. D.F.N. Platel, F. Mangou, and J. Tribouley-Duret Role of glutathione in the detoxification of ferriprotoporphyrin IX in chloroquine resistant Plasmodium berghei Mol. Biochem. Parasitol. 98 1990 215 223
206. V.L. Dubois, D.F.N. Platel, G. Pauly, and J. Tribouley-Duret Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo Exp. Parasitol. 81 1995 117 124
207. R. Mangoyi, R. Hayeshi, B. Ngadjui, F. Ngandeu, M. Bezabih, B. Abegaz, S. Razafimahefa, P. Rasoanaivo, and S. Mukanganyama Glutathione transferase from Plasmodium falciparum - interaction with malagashanine and selected plant natrual products J. Enzyme Inhib. Med. Chem. 25 2010 854 862
208. G.N. Sarma, S.N. Savvides, K. Becker, M. Schirmer, R.H. Schirmer, and P.A. Karplus Glutathione reductase of the malarial parasite Plasmodium falciparum: Crystal structure and inhibitor development J. Mol. Biol. 328 2003 893 907
209. P.M. Farber, L.D. Arscott, C.H. Williams Jr., K. Becker, and R.H. Schirmer Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue FEBS 422 1998 311 314
210. R.K. Haynes, W.C. Chan, H.N. Wong, K.Y. Li, W.K. Wu, K.M. Fan, H.H. Sung, I.D. Williams, D. Prosperi, S. Melato, P. Coghi, and D. Monti Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action Chem. Med. Chem. 5 2010 1282 1299
211. O. Blank, E. Davioud-Charvet, and M. Elhabiri Interactions of the antimalarial drug methylene blue with methemoglobin and heme targets in Plasmodium falciparum: a physico-biochemical study Antioxid. Redox Signal. 2012 10.1089/ars.2011.4239
212. M.E. Selkirk, V.P. Smith, G.R. Thomas, and K. Gounaris Resistance of filarial nematode parasites to oxidative stress Int. J. Parasitol. 28 1998 1315 1332
213. E. Liebau, V.H. Eckelt, G. Wildenburg, P. Teesdale-Spittle, P.M. Brophy, R.D. Walter, and K. Henkle-Dührsenk Structural and functional analysis of a glutathione S-transferase from Ascaris suum Biochem. J. 324 1997 659 666
214. Luersen, S. Muller, A. Hussein, E. Liebau, and R.D. Liebau The gamma-glutamylcysteine synthetase of Onchocerca volvulus Mol. Biochem. Parasitol. 111 2000 243 251
215. S. Muller, T.W. Gilberger, A.H. Fairlamb, and R.D. Walter Molecular characterization and expression of Onchocerca volvulus glutathione reductase Biochem. J. 325 1997 645 651
216. A. Singh, and S. Rathaur Identification and characterization of a selenium-dependent glutathione peroxidase in Setaria cervi Biochem. Biophys. Res. Commun. 331 2005 1069 1074
217. A.S. Hussein, and R.D. Walter Purification and characterization of gamma-glutamyl transpeptidase from Ascaris suum Mol. Biochem. Parasitol. 77 1996 41 47
218. S. Bennuru, R. Semnani, Z. Meng, J.M. Ribeiro, T.D. Veenstra, and T.B. Nutman Brugia malayi excreted/secreted proteins at the host/parasite interface: stage- and gender-specific proteomic profiling PLoS Negl. Trop. Dis. 3 2009 10.1371/journal.pntd.0000410
219. J.P. Hewitson, Y.M. Harcus, R.S. Curwen, A.A. Dowle, A.K. Atmadja, P.D. Ashton, A. Wilson, and R.M. Maizels The secretome of the filarial parasite, Brugia malayi: proteomic profile of adult excretory-secretory products Mol. Biochem. Parasitol. 160 2008 8 21
220. E. Liebau, G. Wildenburg, R.D. Walter, and K. Henkle-Duhrsen A novel type of glutathione S-transferase in Onchocerca volvulus Infect. Immun. 62 1994 4762 4767
221. P.M. Brophy, L.H. Patterson, A. Brown, and D.I. Pritchard Glutathione S-transferase (GST) expression in the human hookworm Necator americanus: potential roles for excretory-secretory forms of GST Acta Trop. 59 1995 259 263
222. J. Rojas, M. Rodríguez-Osorio, and V. Gómez-García Immunological characteristics and localization of the Trichinella spiralis glutathione S-transferase J. Parasitol. 83 1997 360 635
223. A.L. Morassutti, P.M. Pinto, B.K. Dutra, G.T. Oliveira, H.B. Ferreira, and C. Graeff-Teixeira Detection of anti-oxidant enzymatic activities and purification of glutathione transferases from Angiostrongylus cantonensis Exp. Parasitol. 172 2011 365 369
224. P.M. Brophy, and D.I. Pritchard Immunity to helminths: ready to tip the biochemical balance Parasitol. Today 8 1992 419 422
225. B. Zhan, S. Perally, P.M. Brophy, J. Xue, G. Goud, S. Liu, V. Deumic, L.M. De Oliveira, J. Bethony, M.E. Bottazzi, D. Jiang, P. Gillespie, S.H. Xiao, R. Gupta, A. Loukas, N. Ranjit, S. Lustigman, Y. Oksov, and P. Hotez Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus Infect. Immun. 78 2010 1552 1563
226. S. Azeez, R.O. Babu, R. Aykkal, and R. Narayanan Virtual screening and in vitro assay of potential drug like inhibitors from spices against glutathione-S-transferase of filarial nematodes Bioinformation 8 2012 319 325
227. L. Srinivasan, N. Mathew, and K. Muthuswamy In vitro antifilarial activity of glutathione S-transferase inhibitors Parasitol. Res. 105 2009 1179 1182
228. Mathew, L. Srinivasan, T. Karunan, E. Ayyanar, and K. Muthuswamy Studies on filarial GST as a target for antifilarial drug development-in silico and in vitro inhibition of filarial GST by substituted 1,4-naphthoquinones J. Mol. Model. 17 2011 2651 2657
229. S.K. Awasthi, N. Mishra, S.K. Dixit, A. Singh, and M. Yadav Antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme Am. J. Trop. Med. Hyg. 80 2009 764 768
230. S. Gupta, and S. Rathaur Filarial glutathione S-transferase: it's induction by xenobiotics and potential as drug target Acta Biochim. Pol. 52 2005 493 500
231. A.S. Hussein, and R.D. Walter Inhibition of glutathione synthesis of Ascaris suum by buthionine sulfoximine Parasitol. Res. 82 1996 372 374
232. A. Nayak, P. Gayen, P. Saini, N. Mukherjee, and S.P.S. Babu Molecular evidence of curcumin-induced apoptosis in the filarial worm Setaria cervi Parasitol. Res. 2012 10.1007/s00436-012-2948-0
233. V.K. Tiwari, N. Tewari, D. Katiyar, R.P. Tripathi, K. Arora, S. Gupta, R. Ahmad, A.K. Srivastava, M.A. Khan, P.K. Murthy, and R.D. Walter Synthesis and antifilarial evaluation of N1, Nn-xylofuranosylated diaminoalkanes Bioorg. Med. Chem. 11 2003 1789 1800
234. D. Kerboeuf, and J. Aycardi Unexpected increased thiabendazole tolerance in Haemonchus contortus resistant to anthelmintics by modulation of glutathione activity Parasitol. Res. 85 1999 713 718
235. L. Otero, M. Bonilla, A.V. Protasio, C. Fernandez, V.N. Gladyshev, and G. Salinas Thioredoxin and glutathione systems differ in parasitic and free-living platyhelminths BMC Genomics 11 2010 237
236. H.M. Alger, and D.L. Williams The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase Mol. Biochem. Parasitol. 121 2002 129 139
237. D. Ray, and D.L. Williams Characterization of the phytochelatin synthase of Schistosoma mansoni PLoS Negl. Trop. Dis. 5 2011 e1168 10.1371/journal.pntd. 0001168
238. A.N. Kuntz, E. Davioud-Charvet, A.A. Sayed, L.L. Califf, J. Dessolin, E.S. Arnér, and D.L. Williams Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target PLoS Med. 4 2007 e31456 10.1371/journal.pone.0031456
239. W.A. Lea, A. Jadhav, G. Rai, A.A. Sayed, C.L. Cass, J. Inglese, D.L. Williams, C.P. Austin, and A. Simeonov A 1,536-well-based kinetic HTS assay for inhibitors of Shistosoma mansoni thioredoxin glutathione reductase Assay Drug Dev. Technol. 6 2008 551 555
240. A. Simeonov, A. Jadhav, A.A. Sayed, Y. Wang, M.E. Nelson, C.J. Thomas, J. Inglese, D.L. Williams, and C.P. Austin Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade PLoS Negl. Trop. Dis. 2 2008 e127 10.1371/journal.pntd.0000127
241. A.A. Sayed, A. Simenov, C.J. Thomas, J. Inglese, C.P. Austin, and D.L. Williams Identification of oxadiazoles as new drug leads for the control of schistosomiasis Nat. Med. 14 2008 407 412
242. F. Angelucci, A.A. Sayed, D.L. Williams, G. Boumis, M. Brunori, D. Dimastrogiovanni, A.E. Miele, F. Pauly, and A. Bellelli Inhibition of Shistosoma mansoni thioredoxin-glutathione reductase by Auranofin J. Biol. Chem. 284 2009 28977 28985
243. J.J. Martínez-González, A. Guevara-Flores, G. Álvarez, J.L. Rendón-Gómez, and I.P. Del Arenal In vitro killing action of Auranofin on Taenia crassiceps Metacestode (cysticerci) and inactivation of thioredoxin-glutathione reductase (TGR) Parasitol. Res. 107 2010 227 231
244. H. Bártíková, I. Vokřál, L. Skálová, V. Kubíček, J. Firbasová, D. Briestenský, J. Lamka, and B. Szotáková The activity of drug-metabolizing enzymes and the biotransformation of selected anthelmintics in the model tapeworm Hymenolepis diminuta Parasitology 139 2012 809 818
245. S. Scarcella, P. Lamenza, G. Virkel, and H. Solana Expression differential of microsomal and cytosolic glutathione-S-transferases in Fasciola hepatica resistant to triclabendazole Mol. Biochem. Parasitol. 181 2012 37 39
246. L. Harispe, G. Garcia, P. Arbildi, L. Pascovich, C. Chalar, A. Zaha, C. Fernandez, and V. Fernandez Biochemical analysis of a recombinant glutathione transferase from the cestode Echinococcus granulosus Acta Trop. 114 2010 31 36
247. A. Torres-Rivera, and A. Landa Glutathione transferases from parasites: a biochemical view Acta Trop. 105 2008 99 112
248. E. Herrero, J. Ros, G. Belli, and E. Cabiscol Redox control and oxidative stress in yeast cells Biochem. Biophys. Acta 1780 2008 1217 1235
249. J.H. Kim, K.L. Chan, N. Mahoney, and B.C. Campbell Antifungal activity of redox-active benzaldehydes that target cellular antioxidation Ann. Clin. Microbiol. Antimicrob. 10 2011 10.1186/1476-0711-10-23
250. J.H. Kim, B.C. Campbell, N. Mahoney, K.L. Chan, and R.J. Molyneux Chemosensitization of aflatoxigenic fungi to antimycin A and strobilurin using salicylaldehyde, a volatile natural compound targeting cellular antioxidation system Mycopathologia 171 2011 291 298
251. C. Speth, C. Kupfahl, K. Pfaller, M. Hagleitner, M. Deutinger, R. Würzner, I. Mohsenipour, C. Lass-Flörl, and G. Rambach Gliotoxin as putative virulence factor and immunotheraputic target in a cell culture model of cerebral aspergillosis Mol. Immunol. 48 2011 2122 2129
252. R. Zarnowski, K.G. Cooper, L.S. Brunold, J. Calaycay, and J.P. Woods Histoplasma capsulatum secreted γ-glutamyltransferase reduces iron by generating an efficient ferric reductant Mol. Microbiol. 70 2008 352 368
253. R. Zarnowski, and J.P. Woods Glutathione-dependent extracellular ferric reductase activities in dimorphic zoopathogenic fungi Microbiology 151 2005 2233 2240
254. M.M. Timmerman, and J.P. Woods Potential role for extracellular glutathione-dependent ferric reductase in utilization of enviornmental and host ferric compounds by Histoplasma Capsulatum Infect. Immun. 69 2001 7671 7678
255. R. Keays, P.M. Harrison, J.A. Wendon, A. Forbes, C. Gove, G.J. Alexander, and R. Williams Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial BMJ 303 1991 1026 1029
256. U. Hoffmann, M. Fischereder, B. Krüger, W. Drobnik, and B.K. Krämer The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable J. Am. Soc. Nephrol. 15 2004 407 410
257. H. Trivedi, S. Daram, A. Szabo, A.L. Bartorelli, and G. Marenzi High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy Am. J. Med. 122 2009 874.e9
258. E.F. Nash, A. Stephenson, F. Ratjen, and E. Tullis Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis Cochrane Database Syst. Rev. 1 2009 CD007168
259. E.A. Swinyard, and M.A. Pathak Surface-acting drugs Gilman Goodman, The Pharmacological Basis of Therapeutics 6th ed. 1980 Macmillan New York
260. M. Decramer, M. Rutten-van Mölken, P.N. Dekhuijzen, T. Troosters, C. van Herwaarden, R. Pellegrino, C.P. Van Schayck, D. Olivieri, M. Del Donno, W. De Backer, I. Lankhorst, and A. Ardia Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial Lancet 365 2005 1552 1560
261. Evaluating the effectiveness of prednisone, azathioprine, and N-acetylcysteine in people with idiopathic pulmonary fibrosis (PANTHER-IPF) http://clinicaltrials.gov/ct2/show/study/NCT00650091?term=panther&rank=4
262. M. Ozaydin, O. Peker, D. Erdogan, S. Kapan, Y. Turker, E. Varol, F. Ozguner, A. Dogan, and E. Ibrisim N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study Eur. Heart J. 29 2008 625 631
263. L. Yip, and R.C. Dart A 20-hour treatment for acute acetaminophen overdose N. Engl. J. Med. 348 2003 2471 2472
264. A.H. Dawson, D.A. Henry, and J. McEwen Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning Med. J. Aust. 150 1989 329 331
265. M.D. Borges-Santos, F. Moreto, P.C. Pereira, Y. Ming-Yu, and R.C. Burini Plasma glutathione of HIV(+) patients responded positively and differently to dietary supplementation with cysteine or glutamine Nutrition 28 2012 753 756
266. S. Attri, S.V. Rana, and K. Valphei Isoniazid- and rifampicin-induced oxidative hepatic injury - protection by N-acetylcysteine Hum. Exp. Toxicol. 19 2000 517 522 (13)